Published in Endocrinology on March 08, 2007
Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract (2011) 1.45
Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology (2007) 1.23
Ghrelin for cachexia. J Cachexia Sarcopenia Muscle (2010) 1.12
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer (2008) 1.05
Hypothalamic mechanisms in cachexia. Physiol Behav (2010) 1.04
The role of ghrelin in reward-based eating. Biol Psychiatry (2012) 1.03
Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am J Physiol Endocrinol Metab (2008) 1.01
Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile. J Cachexia Sarcopenia Muscle (2014) 0.99
Animal models of anorexia and cachexia. Expert Opin Drug Discov (2009) 0.96
Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model. J Cachexia Sarcopenia Muscle (2012) 0.95
Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. Kidney Int (2010) 0.93
Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle (2015) 0.93
Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model. Support Care Cancer (2013) 0.91
Pathophysiological role of hormones and cytokines in cancer cachexia. J Korean Med Sci (2012) 0.90
Update on melanocortin interventions for cachexia: progress toward clinical application. Nutrition (2009) 0.89
Integrating GHS into the Ghrelin System. Int J Pept (2010) 0.88
The ghrelin axis in disease: potential therapeutic indications. Mol Cell Endocrinol (2011) 0.87
Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations. Int J Pept (2011) 0.86
Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome. Front Pharmacol (2014) 0.85
Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev (2016) 0.84
Ghrelin is an Osteoblast Mitogen and Increases Osteoclastic Bone Resorption In Vitro. Int J Pept (2011) 0.84
Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes? Mol Cell Endocrinol (2011) 0.84
Neuropeptides in the pathophysiology and treatment of cachexia. Curr Opin Support Palliat Care (2010) 0.82
Lycopene enhances antioxidant enzyme activities and immunity function in N-methyl-N'-nitro-N-nitrosoguanidine-enduced gastric cancer rats. Int J Mol Sci (2011) 0.82
Hormonal regulators of appetite. Int J Pediatr Endocrinol (2008) 0.81
Ghrelin in chronic kidney disease. Int J Pept (2010) 0.81
Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment. Curr Opin Support Palliat Care (2013) 0.81
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle. J Cachexia Sarcopenia Muscle (2011) 0.80
Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist. Neurogastroenterol Motil (2014) 0.78
Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review. Endocr Relat Cancer (2016) 0.77
Serum ghrelin levels and gender-related indices of body composition in prepubertal children: a cross-sectional study. Eur J Nutr (2014) 0.77
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia. Endocrine (2016) 0.76
The Pentapeptide RM-131 Promotes Food Intake and Adiposity in Wildtype Mice but Not in Mice Lacking the Ghrelin Receptor. Front Nutr (2015) 0.76
Effects of ghrelin administration on the early postoperative inflammatory response after esophagectomy. Surg Today (2014) 0.76
β1-Adrenergic receptor deficiency in ghrelin-expressing cells causes hypoglycemia in susceptible individuals. J Clin Invest (2016) 0.75
Therapeutic Potential of Targeting the Ghrelin Pathway. Int J Mol Sci (2017) 0.75
Ghrelin Prevents Cisplatin-Induced Testicular Damage by Facilitating Repair of DNA Double Strand Breaks Through Activation of p53 in Mice. Biol Reprod (2015) 0.75
The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy. Int J Mol Sci (2016) 0.75
What can anorexia nervosa teach us about appetite regulation? Nutrition (2011) 0.75
Impact of ghrelin on body composition and muscle function in a long-term rodent model of critical illness. PLoS One (2017) 0.75
Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis. Support Care Cancer (2017) 0.75
Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab (2006) 3.34
Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt (2007) 3.18
Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab (2008) 2.89
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology (2003) 2.14
Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes (2012) 1.91
Engineered microsphere contrast agents for optical coherence tomography. Opt Lett (2003) 1.91
Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A (2009) 1.82
Effect of Agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse. Endocrinology (2004) 1.71
Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic disease. Nat Clin Pract Endocrinol Metab (2006) 1.70
Optical probes and techniques for molecular contrast enhancement in coherence imaging. J Biomed Opt (2005) 1.67
Compressive holography. Opt Express (2009) 1.66
Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer (2005) 1.65
Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol (2003) 1.62
Optical coherence tomography: feasibility for basic research and image-guided surgery of breast cancer. Breast Cancer Res Treat (2004) 1.62
Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J (2004) 1.58
Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130. Endocrinology (2009) 1.58
Gastric bypass up-regulates insulin signaling pathway. Nutrition (2011) 1.54
Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol (2007) 1.53
Impact of Helicobacter pylori eradication on circulating adiponectin in humans. Helicobacter (2012) 1.50
Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab (2008) 1.45
Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice. Development (2003) 1.43
Proteinuria and Reduced Estimated Glomerular Filtration Rate Are Independent Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization. Circ J (2015) 1.42
Association of Estimated Glomerular Filtration Rate and Proteinuria With Lipid-Rich Plaque in Coronary Artery Disease. Circ J (2015) 1.41
Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself. Nat Clin Pract Oncol (2005) 1.41
Temporary adjunctive cilostazol vs clopidogrel loading for ST-segment elevation acute myocardial infarction. Am J Cardiovasc Drugs (2014) 1.40
Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev (2009) 1.38
The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase. Genes Cells (2004) 1.35
Regulation of central melanocortin signaling by interleukin-1 beta. Endocrinology (2007) 1.34
Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. Am J Physiol Regul Integr Comp Physiol (2002) 1.33
Retraction. Nutrition (2005) 1.33
Three-dimensional optical coherence tomography of the embryonic murine cardiovascular system. J Biomed Opt (2006) 1.33
Stabilization of continuum generation from normally dispersive nonlinear optical fibers for a tunable broad bandwidth source for optical coherence tomography. Opt Lett (2007) 1.32
Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology (2005) 1.32
Inverse scattering for optical coherence tomography. J Opt Soc Am A Opt Image Sci Vis (2006) 1.32
Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest (2005) 1.30
Projected index computed tomography. Opt Lett (2003) 1.29
Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition (2005) 1.28
Is obesity an inflammatory disease? Surgery (2003) 1.26
Reliability and validity of the Japanese version of the World Health Organization-Five Well-Being Index in the context of detecting depression in diabetic patients. Psychiatry Clin Neurosci (2007) 1.26
Nonparaxial vector-field modeling of optical coherence tomography and interferometric synthetic aperture microscopy. J Opt Soc Am A Opt Image Sci Vis (2007) 1.25
Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. Endocrinology (2007) 1.24
Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology (2007) 1.23
Near-infrared dyes as contrast-enhancing agents for spectroscopic optical coherence tomography. Opt Lett (2004) 1.23
Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice. Metabolism (2012) 1.22
Localized waveguide formation in germanosilicate fiber transmitting femtosecond IR pulses. J Opt Soc Am B (2008) 1.22
Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci (2011) 1.22
Cancer cachexia--pathophysiology and management. J Gastroenterol (2013) 1.20
Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Surgery (2005) 1.20
Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring) (2012) 1.19
Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.18
Neural control of the anorexia-cachexia syndrome. Am J Physiol Endocrinol Metab (2008) 1.18
Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice. Peptides (2009) 1.16
Optical biopsy of lymph node morphology using optical coherence tomography. Technol Cancer Res Treat (2005) 1.16
Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides (2009) 1.15
Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J Exp Med (2011) 1.15
Design and scaling of monocentric multiscale imagers. Appl Opt (2012) 1.15
Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care (2004) 1.15
Functional optical coherence tomography for detecting neural activity through scattering changes. Opt Lett (2003) 1.15
High-spectral-resolution coherent anti-Stokes Raman scattering with interferometrically detected broadband chirped pulses. Opt Lett (2006) 1.13
Maternal high fat diet is associated with decreased plasma n-3 fatty acids and fetal hepatic apoptosis in nonhuman primates. PLoS One (2011) 1.13
Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation. Endocrinology (2008) 1.13
p73beta is regulated by protein kinase Cdelta catalytic fragment generated in the apoptotic response to DNA damage. J Biol Chem (2002) 1.12
Anorexia in space and possible etiologies: an overview. Nutrition (2002) 1.11
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model. Cancer Immunol Immunother (2008) 1.10
Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol Psychiatry (2008) 1.09
Refeeding syndrome: treatment considerations based on collective analysis of literature case reports. Nutrition (2010) 1.09
A surgical rat model of human Roux-en-Y gastric bypass. J Gastrointest Surg (2004) 1.09
Molecular histopathology by spectrally reconstructed nonlinear interferometric vibrational imaging. Cancer Res (2010) 1.09
Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function. Ann Surg (2008) 1.09
Spatial light interference tomography (SLIT). Opt Express (2011) 1.09
Inverse scattering for high-resolution interferometric microscopy. Opt Lett (2006) 1.09
Bsx, a novel hypothalamic factor linking feeding with locomotor activity, is regulated by energy availability. Endocrinology (2008) 1.08